Southern Westchester Urgent Care PLLC
Southern Westchester Urgent Care PLLC was paid $15.59M by Medicaid between Jan 2018 and Dec 2024, across 61 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 25% of everything it billed.
YONKERS, NY 10710
Next to other Urgent Care Clinic/Center providers in New York
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 683 | $73K | |
| 2019 | 58 | $7K | |
| 2020 | 46,260 | $2.57M | |
| 2021 | 177,426 | $8.25M | |
| 2022 | 76,667 | $3.22M | |
| 2023 | 24,053 | $941K | |
| 2024incomplete | 10,717 | $522K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 25% | 67,146 | 66,145 | $3.86M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 21% | 73,107 | 60,438 | $3.30M |
| S9083 | Global fee urgent care centers | 12% | 19,393 | 16,534 | $1.89M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 12% | 43,507 | 36,719 | $1.84M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 38,626 | 34,207 | $1.70M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.2% | 9,808 | 8,850 | $658K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.1% | 5,946 | 5,751 | $488K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 2.7% | 14,284 | 11,820 | $414K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.6% | 13,996 | 11,287 | $401K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2.4% | 11,394 | 8,423 | $368K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.3% | 5,932 | 5,764 | $197K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,089 | 3,490 | $103K |
49 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 11,000 | $88K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,954 | $51K |
| 0001A | <1% | 1,100 | $43K | |
| 0002A | <1% | 621 | $24K | |
| 0064A | <1% | 341 | $18K | |
| 0011A | <1% | 348 | $14K | |
| 81003 | <1% | 1,969 | $13K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 541 | $11K |
| 0012A | <1% | 235 | $9K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 101 | $9K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 190 | $9K |
| 99000 | <1% | 1,220 | $7K | |
| 0004A | <1% | 146 | $7K | |
| 81025 | <1% | 1,591 | $6K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 247 | $5K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 181 | $4K |
| 90686 | <1% | 162 | $4K | |
| 0031A | <1% | 77 | $4K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 273 | $4K |
| 99205 | Prolong outpt/office vis | <1% | 27 | $3K |
| 0071A | <1% | 50 | $3K | |
| 99201 | <1% | 33 | $2K | |
| 93000 | <1% | 185 | $2K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 33 | $2K |
| 87807 | <1% | 127 | $1K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 30 | $1K |
| 99385 | <1% | 29 | $1K | |
| 0134A | <1% | 30 | $1K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 15 | $1K |
| 0072A | <1% | 18 | $919.39 | |
| 99386 | <1% | 13 | $917.88 | |
| H0033 | Oral medication administration, direct observation | <1% | 137 | $700.90 |
| 0003A | <1% | 13 | $700.00 | |
| 0124A | <1% | 15 | $690.00 | |
| 36410 | <1% | 44 | $584.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 16 | $551.70 |
| 90674 | <1% | 20 | $546.15 | |
| 81002 | <1% | 13 | $530.00 | |
| 90688 | <1% | 45 | $474.54 | |
| 87070 | <1% | 99 | $375.23 | |
| 73630 | <1% | 26 | $307.77 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 48 | $306.11 |
| 99051 | <1% | 86 | $274.00 | |
| 73110 | <1% | 13 | $191.31 | |
| 73610 | <1% | 16 | $170.03 | |
| 87184 | <1% | 54 | $125.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 52 | $25.51 |
| 99429 | 0% | 14 | $0.00 | |
| 90756 | 0% | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.